A Post-Marketing Clinical Pharmacokinetics Study of ART-123 in DIC Subjects With Renal Impairment
Phase of Trial: Phase IV
Latest Information Update: 23 Feb 2017
At a glance
- Drugs Thrombomodulin alfa (Primary)
- Indications Disseminated intravascular coagulation; Embolism and thrombosis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Asahi Kasei
- 23 Feb 2017 Results published in the Thrombosis and Haemostasis Journal.
- 13 Feb 2017 Status changed from recruiting to completed.
- 02 Nov 2012 New trial record